Hyperhomocysteinemia-induced Dyrk1a downregulation results in cardiomyocyte hypertrophy in rats

International Journal of Cardiology

Volumn 145, Issue 2, 2010, Pages 306-307

  Raaf, Lamia ^a,b   Noll, Christophe ^a   Cherifi, Mohamed ^c   Benazzoug, Yasmina ^b   Delabar, Jean Maurice ^a   Janel, Nathalie ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^c Parnet Hospital   (Algeria)

Author keywords

Dyrk1a; Heart; Hyperhomocysteinemia; Hypertrophy; Rats

Indexed keywords

DUAL SPECIFICITY TYROSINE (Y) PHOSPHORYLATION REGULATED KINASE 1A; HOMOCYSTEINE; METHIONINE; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DOWN REGULATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HYPERHOMOCYSTEINEMIA; LETTER; MOUSE; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 78650035589     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.10.043     Document Type: Article

References (12)

1. K. Berenji, M.H. Drazner, B.A. Rothermel, and J.A. Hill Does load-induced ventricular hypertrophy progress to systolic heart failure? Am J Physiol Heart Circ Physiol 289 2005 H8 H16
2. J. Blacher, K. Demuth, and A.P. Guerin Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease J Nephrol 12 1999 248 255
3. J. Sundström, L. Sullivan, and J. Selhub Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study Eur Heart J 25 2004 523 530
4. J. Joseph, L. Joseph, and N.S. Shekhawat Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats Am J Physiol Heart Circ Physiol 285 2003 H679 H686
5. S. Kassab, T. Garadab, and M. Abu-hijleb The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats J Renin Angiotensin Aldosterone Syst 7 2006 206 211
6. B.J. Wilkins, Y.S. Dai, and O.F. Bueno Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy Circ Res 94 2004 110 118
7. Y.J. Suzuki, S.S. Shi, and J.B. Blumberg Modulation of angiotensin II signaling for GATA4 activation by homocysteine Antioxid Redox Signal 1 1999 233 238
8. J.R. Arron, M.M. Winslow, and A. Polleri NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21 Nature 441 2006 595 600
9. C. Kuhn, D. Frank, and R. Will DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy J Biol Chem 284 2009 17320 17327
10. J. Hamelet, C. Noll, C. Ripoll, J.L. Paul, N. Janel, and J.M. Delabar Effect of hyperhomocysteinemia on the protein DYRK1A in liver of mice Biochem Biophys Res Commun 378 2009 673 677
11. S. Kundu, M. Kumar, and U. Sen Nitrotyrosinylation, remodeling and endothelial-myocyte uncoupling in iNOS, cystathionine beta synthase (CBS) knockouts and iNOS/CBS double knockout mice J Cell Biochem 106 2009 119 126
12. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150